Witamax’s investment into DataPathology’s operations in Morocco for MAD 2 million

Lead party: Witamax (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Data Pathology SARL (private company) · Sector: Healthcare, Digital Health Platforms, Telemedicine Providers · Countries of operation: Democratic Republic of the Congo (DRC), Senegal, Morocco Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity…


Lead party: Witamax (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Data Pathology SARL (private company) · Sector: Healthcare, Digital Health Platforms, Telemedicine Providers · Countries of operation: Democratic Republic of the Congo (DRC), Senegal, Morocco

Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Deal amount: US$223,000

Lead investor/buyer: Witamax · Investors/buyers: Witamax

Legal advisers: not identified in the source record.

Source: announced 20 September 2021. Original announcement: techinafrica.com.